IL104132A0 - Compositions for the treatment of mammalian diseases - Google Patents

Compositions for the treatment of mammalian diseases

Info

Publication number
IL104132A0
IL104132A0 IL104132A IL10413292A IL104132A0 IL 104132 A0 IL104132 A0 IL 104132A0 IL 104132 A IL104132 A IL 104132A IL 10413292 A IL10413292 A IL 10413292A IL 104132 A0 IL104132 A0 IL 104132A0
Authority
IL
Israel
Prior art keywords
compositions
treatment
mammalian diseases
mammalian
diseases
Prior art date
Application number
IL104132A
Other languages
English (en)
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL104132A0 publication Critical patent/IL104132A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL104132A 1991-12-20 1992-12-17 Compositions for the treatment of mammalian diseases IL104132A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/812,894 US5342612A (en) 1991-12-20 1991-12-20 Compositions for the treatment of mammalian diseases

Publications (1)

Publication Number Publication Date
IL104132A0 true IL104132A0 (en) 1993-05-13

Family

ID=25210900

Family Applications (1)

Application Number Title Priority Date Filing Date
IL104132A IL104132A0 (en) 1991-12-20 1992-12-17 Compositions for the treatment of mammalian diseases

Country Status (7)

Country Link
US (1) US5342612A (xx)
EP (1) EP0548558A3 (xx)
AU (1) AU3027692A (xx)
CA (1) CA2085799A1 (xx)
HU (1) HUT63335A (xx)
IL (1) IL104132A0 (xx)
ZA (1) ZA929879B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0609739A1 (en) * 1993-02-02 1994-08-10 American Cyanamid Company Method of reversing immunosuppression in vaccines
US6028051A (en) * 1997-07-23 2000-02-22 Ambi Inc. Method for the treatment of staphylococcal disease
US7091332B1 (en) 1998-06-22 2006-08-15 University Of Vermont Treatment of staphylococcus infections
US6875903B2 (en) * 1998-06-22 2005-04-05 University Of Vermont Treatment of Staphylococcus infections
CA2404356A1 (en) * 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
CN1744905A (zh) * 2002-12-10 2006-03-08 百敖新纳斯有限公司 局部抗感染制剂
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
US20050059613A1 (en) * 2003-07-08 2005-03-17 Bahram Memarzadeh Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278378A (en) * 1962-04-19 1966-10-11 Schindler Charles Alvin Staphylococcus-derived antibiotic
US3398056A (en) * 1964-07-10 1968-08-20 Mead Johnson & Co Process for producing lysostaphin by fermentation
US3594284A (en) * 1968-06-04 1971-07-20 Mead Johnson & Co Lysostaphin fermentation with accelerated time cycle
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
FR2518403B1 (fr) * 1981-12-22 1987-01-02 Dietlin Francois Procede de preparation de formes pharmaceutiques presentant une resorption par voie digestive amelioree, et les formes pharmaceutiques ainsi obtenues
US4457916A (en) * 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
US4478822A (en) * 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4469228A (en) * 1983-05-31 1984-09-04 Schering Corporation Interferon kit
US4606918A (en) * 1983-08-22 1986-08-19 Syntex (U.S.A.) Inc. Polyoxypropylene-polyoxyethylene block polymer based adjuvants
US4650674A (en) * 1984-07-05 1987-03-17 Genentech, Inc. Synergistic cytotoxic composition
US4803072A (en) * 1986-09-10 1989-02-07 Smithkline Beckman Corporation Immunomodulation
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US4857506A (en) * 1987-01-12 1989-08-15 American Cyanamid Company Sustained release growth hormone compositions for parenteral administration and their use
US4944941A (en) * 1987-08-07 1990-07-31 Genentech, Inc. Methods and compositions for the treatment of lung conditions
DE68913189T2 (de) * 1988-06-22 1994-05-19 Applied Microbiology Inc Nisin-zusammensetzungen zur anwendung als erhöhte breit-spektrum-bakterizide.
US5135910A (en) * 1988-06-22 1992-08-04 The Public Health Research Institute Of The City Of New York Nisin compositions for use as enhanced, broad range bactericides
AU623864B2 (en) * 1988-08-29 1992-05-28 Applied Microbiology, Inc Method of treating mastitis and other staphylococcal infections
US4980163A (en) * 1989-03-01 1990-12-25 Public Health Research Institute Of The City Of New York Novel bacteriocin compositions for use as enhanced broad range bactericides and methods of preventing and treating microbial infection
US5124145A (en) * 1989-10-24 1992-06-23 Ciba-Geigy Canada Ltd. Method for the prevention and treatment of bovine mastitis
EP0448091B1 (en) * 1990-03-23 1998-08-05 The Green Cross Corporation Pharmaceutical composition containing slightly water-soluble drug
US5071644A (en) * 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels

Also Published As

Publication number Publication date
EP0548558A3 (en) 1993-10-13
ZA929879B (en) 1993-07-02
HUT63335A (en) 1993-08-30
CA2085799A1 (en) 1993-06-21
US5342612A (en) 1994-08-30
HU9204028D0 (en) 1993-04-28
EP0548558A2 (en) 1993-06-30
AU3027692A (en) 1993-06-24

Similar Documents

Publication Publication Date Title
AU2806692A (en) Medicament for the treatment of anxiety
BG49522A1 (en) Pharmaceutist composition accelarating the healing of mounds
IL104132A0 (en) Compositions for the treatment of mammalian diseases
EP0524602A3 (en) Compositions for the treatment of inflammations of the skin
GB9323088D0 (en) Novel process for the preparation of benzylformimidate
IT1271567B (it) Procedimento per l'ulteriore trattamento di salcicce
IL105285A0 (en) Compositions for the treatment of diabetes
AU638829B2 (en) Composition for disinfecting water by the electrochlorination process and use of this composition
AU1541088A (en) Composition for the treatment of the epiderm
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
EP0538729A3 (en) Process for the preparation of cycloalkanols
EP0333490A3 (en) Composition for the treatment of hepatopathy composition for the treatment of hepatopathy
IL104756A0 (en) Composition for the treatment of glaucoma
HU905312D0 (en) Preparation for the treating of psoriasis topicalis
AU5018893A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
ZA944671B (en) Medicaments for the treatment of inflammatory diseases
AP9000180A0 (en) Pharmaceutical composition for the treatment of protozoal diseases
GB9016062D0 (en) Process for the preparation of acrylates
EP0460690A3 (en) Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
IL108924A0 (en) Compositions for the treatment of eye diseases
HU895550D0 (en) Compositions for the treatment of leishmaniasis
IL82295A (en) Compositions for treatment of the eyes
GB9104920D0 (en) Therapeutical composition for the treatment of multiple sclerosis
GB2246131B (en) Process for the preparation of acrylates